Related Experiment Video
Updated: Jun 25, 2025
07:49
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
1.3K
[Rhythm management in patients with heart failure]
Richard Kobza1, Benjamin Berte2
1Cardiopuls Medical Center Luzern, Luzern, Switzerland, richard.kobza@cardiopuls.ch.
Therapeutische Umschau. Revue Therapeutique
|May 23, 2024
Summary
Managing arrhythmias in heart failure requires a comprehensive strategy. Early rhythm control, including catheter ablation, improves outcomes for heart failure patients with arrhythmias.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Arrhythmias are common in heart failure, increasing mortality risk.
- Current risk stratification for sudden cardiac death in heart failure is challenging.
- Antiarrhythmic drugs offer symptomatic relief but not prognostic benefit.
Purpose of the Study:
- To review current strategies for managing arrhythmias in heart failure.
- To highlight the role of early rhythm control, including catheter ablation.
- To emphasize a multidimensional approach to arrhythmia management in heart failure.
Main Methods:
- Review of recent clinical studies and data on arrhythmia management in heart failure.
- Analysis of the prognostic impact of different therapeutic strategies.
- Synthesis of evidence for device-based and interventional therapies.
Main Results:
- Early consideration of catheter ablation for ventricular tachycardias is supported by recent data.
- Early rhythm control strategies, especially catheter ablation, show positive prognostic impact in heart failure with atrial fibrillation.
- A systematic, multidimensional approach integrating medical, device, and interventional therapies is crucial.
Conclusions:
- Holistic management of arrhythmias in heart failure necessitates an integrated approach.
- Early rhythm control, particularly catheter ablation, offers significant prognostic advantages.
- Further research and clinical implementation of early rhythm control strategies are warranted.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.5K
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
762
Related Concept Videos
01:30Pulse rhythm
785
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
785
01:28Disturbances in Heart Rhythm
936
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
936
01:26Heart Failure Drugs: Inotropic Agents
570
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
570
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
01:14Decreased pulse rate
537
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
537
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336